More from Announcements


$6M grant for new Open Science patient registry

Goal is to accelerate research and let patients know how their data is helping find treatments

A $6M grant from Brain Canada will fund the creation of a new Open Science patient registry, to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.

Published: 28 Apr 2023

Study finds obesity-related neurodegeneration mimics Alzheimer’s disease

Thinning in the right temporo-parietal cortex and left prefrontal cortex were similar in both groups

A new study led by scientists at The Neuro (Montreal Neurological Institute-Hospital) of McGill University finds a correlation between neurodegeneration in obese people and Alzheimer’s disease (AD) patients.

Email address:
Published: 31 Jan 2023

Neuro director to co-chair new national clinical trial initiative

Consortium brings together hundreds of researchers from 28 networks, 11 trial units across the country

Today the Canadian Institutes of Health Research (CIHR) announced funding for a new clinical trial consortium co-chaired by Dr.

Published: 19 Jan 2023

Frequent genetic cause of late-onset ataxia uncovered by a Quebec-led international collaboration

Discovery will improve diagnosis and open treatment possibilities for thousands of people with this debilitating neurodegenerative condition worldwide

A new study published on Dec. 14, 2022 in the New England Journal of Medicine reports the identification of a previously unknown genetic cause of a late-onset cerebellar ataxia, a discovery that will improve diagnosis and open new treatment avenues for this progressive condition.

Email address:
Published: 15 Dec 2022

A one-stop-shop for brain imaging

Software tool brings together multiple brain maps in one place

The brain is a complex organ, and no one imaging mode can catch everything that’s going on inside it. Over the years, multiple “brain maps” have emerged, each focusing on different brain processes, from metabolism to cognitive function. While these maps are important, using them in isolation limits the discoveries researchers can make from them.

Email address:
Published: 6 Oct 2022

Quebec study on long COVID seeking participants

Purpose is to understand post-COVID symptom evolution and impact on patients’ lives

As of Sept. 20, 2022, there have been more than 1.1 million cases of COVID-19 in Quebec. It is estimated that 10 to 30 per cent of cases will have lingering symptoms after the acute illness. This means that as many as 330,000 Quebecers may experience what’s become known as long COVID, or post-COVID-19 syndrome.

Email address:
Published: 20 Sep 2022

Two Neuro faculty inducted into The Royal Society of Canada

Society recognizes distinguished Canadians who have made remarkable contributions to their academic fields and public life

Two faculty members at The Neuro (Montreal Neurological Institute-Hospital) have been inducted into The Royal Society of Canada (RSC), recognizing their contributions to our understanding of neuroscience and the human brain.

Published: 6 Sep 2022

Changing how we value research

The Neuro joins two other McGill-affiliated organizations in signing The Declaration on Research Assessment

The Neuro (Montreal Neurological Institute-Hospital) has joined the Douglas Research Centre (DRC) and the Canadian Open Neuroscience Platform (CONP) in signing the San Francisco Declaration on Research Assessment (DORA), an agreement that seeks to change how scholarly research contributions are valued in hiring, promotion, and funding decisions.

Published: 10 Aug 2022

Boris Bernhardt wins CAN's 2022 New Investigator Award

Together with Dr. Birgit Frauscher, Bernhardt co-directs The Neuro’s new Centre of Excellence in Epilepsy

Since joining The Neuro in 2016, Boris Bernhardt, PhD, Assistant Professor of Neurology and Neurosurgery, has published pioneering research on the organization and development of the healthy brain. His achievements have been recognized this week by the Canadian Association for Neuroscience, who have awarded him the 2022 New Investigator Award.

Published: 12 Apr 2022

Douglas Research Centre joins The Neuro in Open Science

Five-point strategy will maximize the impact of research and maintain leadership in mental health research and care

Today the Douglas Research Centre (DRC) joins The Neuro’s Tanenbaum Open Science Institute (TOSI) as a partner in research data sharing and collaboration through the adoption of a set of institutional Open Science principles.

Published: 29 Mar 2022

Largest ever psychedelics study maps changes of conscious awareness to neurotransmitter systems

Applying machine learning to a database of testimonials uncovers how drug-induced changes in subjective awareness are mechanistically rooted in the human brain

Psychedelics are now a rapidly growing area of neuroscience and clinical research, one that may produce much-needed new therapies for disorders such as depression and schizophrenia. Yet there is still a lot to know about how these drug agents alter states of consciousness.

Email address:
Published: 16 Mar 2022

Open Science antibody characterization project receives $4-million grant

YCharOS is an independent quality assessment initiative to improve research results 

An antibody characterization project with partners at The Neuro will be able to expand thanks to funding from Génome Québec.  

Published: 14 Mar 2022

Artificial intelligence tutoring outperforms expert instructors in neurosurgical training

Machine learning algorithms enhanced technical performance and learning outcomes during simulated brain tumor removal

The COVID-19 pandemic has presented both challenges and opportunities for medical training. Remote learning technology has become increasingly important in several fields. A new study finds that in a remote environment, an artificial intelligence (AI) tutoring system can outperform expert human instructors.

Email address:
Published: 22 Feb 2022

Neuro Genomics Partnership aims to drive neurological disease research

Academia and industry collaborate to find new targets for neurological disease treatment

A new research collaboration between The Neuro (Montreal Neurological Institute-Hospital), Takeda Development Center Americas, Inc. and Roche will enable large-scale analysis of patient data to potentially find promising targets for drug development in neurological diseases.

Published: 3 Feb 2022

New Quebec neuroscience partnership awarded $7M

The Neuro and the CERVO Brain Research Centre join forces to pave the way for much needed biomarker discovery in brain diseases

The Neuro-CERVO Alliance for Drug Discovery (NCADD), a new partnership between The Neuro (Montreal Neurological Institute-Hospital) at McGill University and the CERVO Brain Research Centre of the CIUSSS de la Capitale-Nationale, affilitated with l’Université Laval, was awarded $7M CAD in funding over three years from the Ministry of Economy and Innovation

Email address:
Published: 13 Dec 2021


The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates


The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.




Back to top